Speaker Profile
Christopher C. Gibson

Christopher C. Gibson MD, PhD

Biotechnology, Geriatrics, Healthcare Management, Healthcare Technology
Salt Lake City, Utah, United States of America

Connect with the speaker?

Dr. Chris is the co-founder and CEO of Recursion Pharmaceuticals, a drug discovery company which he spun-out of the University of Utah in 2013. Chris has undergraduate degrees in Bioengineering and Business from Rice University. Prior to forming Recursion, Chris was enrolled in the MD/PhD program at the University of Utah.

After completion of the Ph.D. training in Bioengineering, he took an indeterminate leave of absence from completion of medical school to build Recursion into a cutting-edge discoverer of new ways to treat genetic diseases. Recursion combines experimental biology and bioinformatics to evaluate millions of potential new uses for known drugs in the rare disease space. Chris is the PI of a $1.4M grant from NCATS that is enabling Recursion, along with private funds, to broaden its repositioning work across thousands of genetic disease models.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)